Investing.com - Biosig Tech reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Biosig Tech announced earnings per share of $-0.140 on revenue of $135.0K. Analysts polled by Investing.com EPS of $-0.137 on revenue of $434.67K.
Biosig Tech 's are down 81% and is trading at $0.423 , still down 89.68% from its 52 week high of $4.10 set on Thursday, November 18, 2021.
Biosig Tech follows other major Healthcare sector earnings this month
Biosig Tech's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.78 on revenue of $22.6B, for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar